Sustainable Insight Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-531
Closed -$244K 70
2023
Q1
$244K Sell
531
-76
-13% -$36.2K 0.25% 71
2022
Q4
$311K Buy
+607
New +$308K 0.35% 65
2022
Q1
Sell
-462
Closed -$214K 124
2021
Q4
$214K Sell
462
-102
-18% -$42.9K 0.11% 115
2021
Q3
$210K Buy
564
+6
+1% +$2.28K 0.13% 108
2021
Q2
$213K Buy
+558
New +$213K 0.13% 117
2021
Q1
Sell
-632
Closed -$203K 121
2020
Q4
$203K Buy
+632
New +$194K 0.14% 110

Other funds holding ELV

Sustainable Insight Capital Management's ELV Position: Q2 2023 in Review

Sustainable Insight Capital Management sold out of Elevance Health (ELV) in Q2 2023, closing a stake of 531 shares — an estimated $244K sold.

Sustainable Insight Capital Management first reported a position in ELV in Q4 2020 and held it in 6 quarters. The position peaked at $311K in Q4 2022. 1,523 funds tracked by Wall St. Rank hold ELV as of Q2 2023.

  • Sustainable Insight Capital Management reported no remaining Elevance Health position as of Q2 2023 after selling out during the quarter.
  • Sustainable Insight Capital Management sold 531 Elevance Health shares in Q2 2023, an estimated $244K.
  • Sustainable Insight Capital Management first reported a position in Elevance Health in Q4 2020 and held it in 6 quarters.
  • Sustainable Insight Capital Management's Elevance Health position peaked at $311K in Q4 2022.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q2 2023.

Based on Sustainable Insight Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.